Provided by Tiger Trade Technology Pte. Ltd.

Biogen

222.82
-3.0600-1.35%
Post-market: 223.200.3800+0.17%19:42 EDT
Volume:1.76M
Turnover:394.33M
Market Cap:32.90B
PE:39.58
High:228.31
Open:225.50
Low:222.50
Close:225.88
52wk High:230.49
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.45
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.75
PE(LYR):25.35

Loading ...

Biogen Completes Acquisition of Raythera Inc.

THOMSON REUTERS
·
Aug 07

Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story

TIPRANKS
·
Aug 07

Biogen Director Lloyd Minor Disposes of 1,186 Common Shares Worth $240,351.94

Reuters
·
Aug 06

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Biogen price target raised to $241 from $221 at Mizuho

TIPRANKS
·
Aug 04

From Products to Innovation: Three Emerging Sectors Anchor China's Economic Growth in 2025

Deep News
·
Aug 04

Stoke Therapeutics Q2 Revenue Falls 33% on Lower Collaboration, Licensing Income

Reuters
·
Aug 04

Biogen is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 04

Mizuho Securities Keeps Their Buy Rating on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen : Citigroup Raises Target Price to $215 from $200

THOMSON REUTERS
·
Aug 03

Stifel Nicolaus Remains a Buy on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Biogen, Inc : H.c. Wainwright Raises Target Price to $251 from $237

THOMSON REUTERS
·
Jul 30

Biogen is Maintained at Neutral by Wedbush

Dow Jones
·
Jul 30

Biogen price target lowered to $240 from $242 at RBC Capital

TIPRANKS
·
Jul 30

Alnylam Q2 Revenue Rises 67% on Increased Demand for Amvuttra

Reuters
·
Jul 30

Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Revenue Rises 71% on Rezdiffra Demand

Reuters
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30